Home › NDC Lookup › RxCUI directory › RxCUI 997264

250 ML sipuleucel-T 200000 CELLS/ML Injection — RxCUI 997264

RxNorm drug concept · Semantic clinical drug
RxCUI 997264 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 1 package NDC Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI997264
Official name250 ML sipuleucel-T 200000 CELLS/ML Injection
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known assipuleucel-T 50,000,000 CELLS per 250 ML Injection; sipuleucel-T 50,000,000 CELLS in 250 ML Injection
FDA products mapped1
Package NDCs mapped1
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Sipuleucel-T Injection: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Provenge is unlike most cancer treatments. It's actually made from your own white blood cells. Before each dose, your cells are collected, sent to a lab where they're trained to re...
  • What exactly is Provenge, and how is it different from regular cancer drugs?
  • The infusion itself takes about 60 minutes, and you'll be observed for at least 30 minutes afterward. The most common things people experience are chills, fever, and fatigue — thes...
  • What should I expect during and after each infusion?
📖 Read our full Sipuleucel-T Injection guide →

🕸️ Concept Web — How 250 ML sipuleucel-T 200000 CELLS/ML Injection Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept 250 ML sipuleucel-T 200000 CELLS/ML Injection RxCUI 997264

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Sipuleucel-T 997261
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Provenge 978086
  3. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Sipuleucel-T Injection 1726181
    • Sipuleucel-T Injectable Product 1159660
    • Sipuleucel-T Injection [Provenge] 1726183
    • Provenge Injectable Product 1182470
    • Injection 1649574
    • Injectable Product 1151126
  4. Clinical & branded drugs 3

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 11 of 11 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Sipuleucel-T 200000 CELLS/ML SCDC · 997262
  • Sipuleucel-T Injection SCDF · 1726181
  • Sipuleucel-T Injectable Product SCDG · 1159660

Brand-Name Concepts

📦 FDA Products & Package NDCs

1 product · 1 package NDC
1 package NDC map to RxCUI 997264 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
30237-8900-06 1 BAG in 1 CARTON (30237-8900-6) / 1 INJECTION in 1 BAG (30... PROVENGE Dendreon Pharmaceuticals LLC 2010-04-29
Observed labelers: Dendreon Pharmaceuticals LLC (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
Q2043 Sipuleucel-t auto cd54+ 1 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.